QIAGEN bioinformatics and NGS solutions enable genomic breakthroughs

QIAGEN and CENTOGENE to collaborate in bioinformatics for genetic diseases

QIAGEN launches fourth-generation QuantiFERON®-TB Gold Plus in the U.S.

QIAGEN achieves ISO certification for state-of-the-art quality in forensics

QIAGEN N.V. announces successful completion of non-U.S. offer involving convertible notes

Ad-hoc announcement pursuant to Art. 17 MAR

QIAGEN and Clinical Genomics partner on liquid biopsies to monitor patients for recurrence of colorectal cancer

Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 (MAR) and the Delegated EU Regulation 2016/1052 / Share Repurchase

QIAGEN reports results for second quarter and first half of 2017

DiaSorin and QIAGEN sign collaboration to expand liaison test menu through adoption of select QIAGEN assays